Become Affiliate

PepFlow

Download

CJC-1295 (no DAC) dosage

Review short-acting CJC-1295 without DAC, including injection frequency, gradual progressions and timing around daily routines. Calculate volume and syringe units using your own vial inputs.

Full CJC-1295 (no DAC) library reference

CJC-1295 (no DAC) dosage chart

This summary table compares available dose amounts and schedules by administration route.

RouteDoseFrequency & duration
Injectable100–200 mcg1–3x daily · 8–12 wk

CJC-1295 (no DAC) dosage by administration route

CJC-1295 (no DAC) injectable dosage

Reported-use amounts for CJC-1295 (no DAC) are 100–200 mcg per administration, 1–3x daily, for 8–12 wk. A gradual subcutaneous progression starts at 100 mcg in weeks 1–2, increases to 150 mcg in weeks 3–4, then reaches 200–300 mcg in weeks 5–12. Schedules include once-daily administration and a separate two-to-three-times-weekly pattern.[12][13]

The no-DAC form is a short-acting Modified GRF 1-29 analogue. Its pulse-oriented GH signaling differs from the prolonged action of DAC-containing CJC-1295.[1][2][3][4][5][12]

Frequency and timing

Common injection timing is morning, after a workout or before bed.[2][12]

Cycle length and breaks

Injectable: 8–12 wk. A standard break interval between courses is not established.[12]

CJC-1295 (no DAC) dosage calculator

Convert your chosen CJC-1295 (no DAC) amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.

CJC-1295 (no DAC) dosage calculator

Editable calculation example. Enter your chosen amount and the details of your vial; these starting values are not a recommended dose.

mcg
mg
mL
Concentration
1.66667mg/mL
Draw units
—units
Total doses
—
Volume per dose
—mL
Daily amount
—mcg
Complete days per vial
—
Open the full peptide calculator →

CJC-1295 (no DAC) safety and side effects

Approval and product quality

CJC-1295 (no DAC) is not an FDA-approved drug.[10]

Side effects and long-term safety

Injection-site reactions, flushing, headache, dizziness, blood-pressure symptoms and faster heart rate are relevant adverse effects. Long-term endocrine safety, glucose effects, interactions and product purity remain uncertain.[6][7][5][11]

Route-specific dosing limits

GH/IGF-1 effects and anti-doping restrictions require attention. Medical review is especially important for endocrine disease, glucose dysregulation, cancer or growth-factor-sensitive histories, pregnancy, breastfeeding, pediatric use, and competitive sport. Reported-use injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[10][7][13][12]

Stacks that include CJC-1295 (no DAC)

Open a stack dosage guide for its component amounts, schedules and supporting information.

For a blend calculation, each component's amount and the final volume must be known. A total blend weight alone cannot tell you the dose of each component.

Common CJC-1295 (no DAC) dosage questions

What is the CJC-1295 no DAC dose?

Common Modified GRF 1-29 protocols usually use 100-200 mcg per dose, 1-3 times daily, with morning, post-workout, or before-bed timing.

Is there a standard human dose of CJC-1295 (no DAC)?

A transferable human dose for CJC-1295 (no DAC) has not been established. A product strength or reminder amount does not establish a treatment regimen.[12]

Does CJC-1295 (no DAC) have a standard cycle or break interval?

Injectable: 8–12 wk. A standard break interval between courses is not established.[12]

Sources

Show citationsHide citations

Keep It Organized

Stay on track with your long-term goals.

Use PepFlow to record your CJC-1295 (no DAC) protocol, set reminders for your own schedule, and review your history.

Download on the App StoreGet it on Google Play
PepFlow calendar on Thursday, April 9, listing BPC-157 at 10:00 and GHK-CU at 18:00